Spots Global Cancer Trial Database for A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
Official Title: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
Study ID: NCT03278028
Conditions
Study Description
Brief Summary: The primary objective of this study is to evaluate the effectiveness of A-101 compared to Vehicle when applied to 1 Target common wart on the trunk or extremities twice a week.
Detailed Description: The primary objective of this study is to evaluate the effectiveness of A-101 compared to Vehicle when applied to 1 Target common wart on the trunk or extremities twice a week. The secondary objectives of this study are to evaluate the clinical effect of A-101 when applied to all treated Warts (Target Warts plus Non-Target Warts) twice a week, duration of response in all treated Warts (Target Warts plus Non-Target Warts), and safety of A-101.
Keywords
Eligibility
Minimum Age: 8 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Aclaris Investigational Site, Glendale, Arizona, United States
Aclaris Investigational Site, Fort Smith, Arkansas, United States
Aclaris Investigational Site, Encinitas, California, United States
Aclaris Investigational Site, Los Angeles, California, United States
Aclaris Investigational Site, Denver, Colorado, United States
Aclaris Investigational Site, Omaha, Nebraska, United States
Aclaris Investigational Site, Albuquerque, New Mexico, United States
Aclaris Investigational Site, Rochester, New York, United States
Aclaris Investigational Site, High Point, South Carolina, United States
Aclaris Investigational Site, Knoxville, Tennessee, United States
Aclaris Investigational Site, Nashville, Tennessee, United States
Aclaris Investigational Site, College Station, Texas, United States
Aclaris Investigational Site, Houston, Texas, United States
Aclaris Investigational Site, Salt Lake City, Utah, United States
Aclaris Investigational Site, Lynchburg, Virginia, United States
Aclaris Investigational Site, Norfolk, Virginia, United States
Contact Details
Name: Stuart D Shanler, MD
Affiliation: Aclaris Therapeutics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
